Data will be reviewed after a study volunteer experienced an unexpected illness
News
NICE no for Pierre Fabre’s Braftovi
Preliminary guidelines reject NHS funding for the drug for BRAF V600E mutation-positive metastatic colorectal cancer
SMC accepts 14 new medicines for use by NHS Scotland
The decisions bring a raft of new treatment options for conditions including epilepsy, depression and cancer
Verona begins pilot study of potential COVID-19 inhaler
Inhaled ensifentrine will be assessed in hospitalised patients
EU expands scope of Imbruvica to include untreated CLL patients
Treatment naïve patients lived longer without disease progression with the Imbruvica-based regimen than those given a chemotherapy-based one
Genentech’s Gavreto cleared for RET non-small cell lung cancer
The personalised cancer treatment has received conditional approval in the US
High-dose Enerzair Breezhaler further cuts asthma exacerbations
New analysis shows high-dose, once-daily Enerzair Breezhaler cut asthma exacerbation rates by 21% (moderate or severe) and 31% (severe) versus medium-dose
Gonorrhoea cases hit highest level since records began
Almost 71,000 cases were diagnosed in 2019, prompting new warnings on the need to practice safe sex
Destiny, SporeGen collaborate on COVID-19 prevention spray
Development of SPOR-COV is supported by a grant from Innovate UK
EMA begins review of Dexamethasone Taw for COVID-19
The medicine is being assessed for treating adults hospitalised with the virus
Janssen’s lead coronavirus vaccine shows preclinical promise
The findings have validated confidence in the experimental vaccine, the firm noted
CR UK, AZ researchers pioneer new antibody maturation technique
The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major human diseases
Corticosteroids boost survival rates for COVID-19 patients
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Immunotherapies could target aggressive pancreatic cancer, research indicates
Scientists have discovered that hard-to-treat pancreatic cancer hijacks a key immune system response
UK bladder cancer patients get early access to Bavencio
UK MHRA has issued positive scientific opinion enabling the drug’s inclusion on the Early Access to Medicines Scheme
